highlight
use
enter
target
cell
sarscov
bind
similar
affin
structur
spike
glycoprotein
two
conform
sarscov
polyclon
antibodi
inhibit
spikemedi
entri
cell
brief
newli
emerg
pathogen
spread
worldwid
bind
high
affin
human
use
entri
receptor
invad
target
cell
cryoem
structur
spike
glycoprotein
two
distinct
conform
along
inhibit
spikemedi
entri
sarscov
polyclon
antibodi
provid
blueprint
design
vaccin
therapeut
emerg
result
infect
death
coronaviru
spike
glycoprotein
promot
entri
cell
main
target
antibodi
show
use
enter
cell
receptorbind
domain
sarscov
bind
similar
affin
human
correl
effici
spread
among
human
found
glycoprotein
harbor
furin
cleavag
site
boundari
subunit
process
biogenesi
set
viru
apart
sarscov
sarsrel
cov
determin
cryoem
structur
ectodomain
trimer
provid
blueprint
design
vaccin
inhibitor
viral
entri
final
demonstr
sarscov
murin
polyclon
antibodi
potent
inhibit
mediat
entri
cell
indic
crossneutr
antibodi
target
conserv
epitop
elicit
upon
vaccin
three
coronavirus
cross
speci
barrier
caus
deadli
pneumonia
human
sinc
begin
st
centuri
sever
acut
respiratori
syndrom
coronaviru
sarscov
drosten
et
al
ksiazek
et
al
middleeast
respiratori
syndrom
coronaviru
zaki
et
al
merscov
zhu
et
al
sarscov
emerg
guangdong
provinc
china
spread
five
contin
air
travel
rout
infect
peopl
caus
death
merscov
emerg
arabian
peninsula
remain
major
public
health
concern
export
countri
infect
total
individu
claim
live
previous
unknown
coronaviru
name
discov
decemb
wuhan
hubei
provinc
china
sequenc
isol
januari
zhou
et
al
zhu
et
al
associ
ongo
outbreak
atyp
pneumonia
affect
peopl
kill
affect
countri
march
januari
world
health
organ
declar
epidem
public
health
emerg
intern
concern
merscov
suggest
origin
bat
reservoir
host
fuel
spillov
human
unequivoc
dromedari
camel
haagman
et
al
memish
et
al
sarscov
close
relat
origin
bat
like
serv
reservoir
host
two
virus
ge
et
al
hu
et
al
li
et
al
yang
et
al
zhou
et
al
wherea
palm
civet
racoon
dog
recogn
intermedi
host
zoonot
transmiss
sarscov
bat
human
guan
et
al
kan
et
al
wang
et
al
intermedi
host
remain
unknown
recurr
spillov
coronavirus
human
along
detect
numer
coronavirus
bat
includ
mani
sarsrel
coronavirus
sarsrcov
suggest
futur
zoonot
transmiss
event
may
continu
anthoni
et
al
ge
et
al
hu
et
al
li
et
al
menacheri
et
al
menacheri
et
al
yang
et
al
zhou
et
al
addit
highli
pathogen
zoonot
pathogen
sarscov
merscov
belong
bcoronaviru
genu
four
lowpathogen
coronavirus
endem
human
date
therapeut
vaccin
approv
humaninfect
coronavirus
coronaviru
entri
host
cell
mediat
transmembran
spike
glycoprotein
form
homotrim
protrud
viral
surfac
compris
two
function
subunit
respons
bind
host
cell
receptor
subunit
fusion
viral
cellular
membran
subunit
mani
cov
cleav
boundari
subunit
remain
noncoval
bound
prefus
conform
bosch
et
al
burkard
et
al
kirchdoerf
et
al
millet
whittak
cell
march
elsevi
inc
park
et
al
wall
et
al
distal
subunit
compris
receptorbind
domain
contribut
stabil
prefus
state
membraneanchor
subunit
contain
fusion
machineri
gui
et
al
kirchdoerf
et
al
pallesen
et
al
song
et
al
wall
et
al
wall
et
al
yuan
et
al
cov
cleav
host
proteas
socal
site
locat
immedi
upstream
fusion
peptid
madu
et
al
millet
whittak
cleavag
propos
activ
protein
membran
fusion
via
extens
irrevers
conform
chang
healdsarg
gallagh
whittak
park
et
al
wall
et
al
result
coronaviru
entri
suscept
cell
complex
process
requir
concert
action
receptorbind
proteolyt
process
protein
promot
viruscel
fusion
differ
coronavirus
use
distinct
domain
within
subunit
recogn
varieti
attach
entri
receptor
depend
viral
speci
endem
human
coronavirus
attach
via
domain
found
glycoprotein
glycolipid
host
cell
surfac
enabl
entri
suscept
cell
hulswit
et
al
vlasak
et
al
merscov
howev
use
domain
recogn
nonacetyl
sialosid
attach
receptor
park
et
al
like
promot
subsequ
bind
domain
b
b
entri
receptor
dipeptidylpeptidas
lu
et
al
raj
et
al
sarscov
sever
sarsrel
coronavirus
sarsrcov
interact
directli
angiotensinconvert
enzym
via
b
enter
target
cell
ge
et
al
kirchdoerf
et
al
li
et
al
li
et
al
song
et
al
yang
et
al
coronaviru
glycoprotein
surfaceexpos
mediat
entri
host
cell
main
target
neutral
antibodi
ab
upon
infect
focu
therapeut
vaccin
design
trimer
extens
decor
nlink
glycan
import
proper
fold
rossen
et
al
modul
access
host
proteas
neutral
ab
wall
et
al
wall
et
al
xiong
et
al
yang
et
al
previous
character
potent
humanneutr
ab
rare
memori
b
cell
individu
infect
sarscov
traggiai
et
al
merscov
corti
et
al
complex
sarscov
merscov
provid
molecularlevel
inform
mechan
competit
inhibit
b
attach
host
receptor
antisarscov
ab
also
act
function
mimick
receptor
attach
promot
fusogen
conform
rearrang
ratchet
mechan
elucid
uniqu
natur
coronaviru
membran
fusion
activ
report
could
mediat
smediat
entri
cell
establish
function
receptor
newli
emerg
coronaviru
b
engag
human
compar
affin
sarscov
b
viral
isol
associ
epidem
ie
bind
high
affin
tight
bind
could
partial
explain
effici
transmiss
human
case
sarscov
identifi
presenc
unexpect
furin
cleavag
site
boundari
cleav
biosynthesisa
novel
featur
set
viru
apart
sarscov
sarsrcov
abrog
cleavag
motif
moder
affect
smediat
entri
bhk
cell
may
contribut
expand
tropism
viru
report
sever
highli
pathogen
avian
influenza
virus
pathogen
newcastl
diseas
viru
klenk
garten
steinhauer
determin
cryoelectron
microscopi
cryoem
structur
entri
mlv
pseudotyp
sarscov
furmut
cell
data
repres
mean
standard
deviat
technic
triplic
b
entri
mlv
pseudotyp
furmut
bhk
cell
transient
transfect
experi
carri
two
independ
pseudoviru
prepar
repres
experi
shown
data
repres
mean
standard
deviat
technic
triplic
c
sequenc
align
multipl
relat
sarscov
sarsrcov
glycoprotein
reveal
introduct
furin
cleavag
site
novel
coronaviru
ident
similar
posit
respect
shown
white
red
font
four
amino
acid
residu
insert
posit
indic
period
entir
sequenc
align
present
data
western
blot
analysi
sarscov
smlv
smlv
furmut
mlv
pseudovirion
see
also
data
ectodomain
trimer
reveal
adopt
multipl
b
conform
reminisc
previou
report
sarscov
merscov
final
show
sarscov
mous
polyclon
sera
potent
inhibit
entri
target
cell
pseudotyp
virus
collect
result
pave
way
design
vaccin
elicit
broad
protect
sarscov
sarsrcov
glycoprotein
share
amino
acid
sequenc
ident
sarscov
urbani
ident
bat
sarsrcov
glycoprotein
latter
two
sarsrcov
sequenc
identifi
rinolophu
sinicu
chines
horsesho
bat
speci
sarsrcov
isol
ge
et
al
yang
et
al
furthermor
zhou
et
al
recent
report
close
relat
bat
sarsrcov
form
distinct
lineag
sarsrcov
glycoprotein
share
amino
acid
sequenc
ident
sarscov
recogn
entri
receptor
surfac
type
ii
pneumocyt
use
b
share
overal
amino
acid
sequenc
ident
b
ident
within
receptorbind
motif
rbm
li
et
al
li
et
al
li
et
al
wan
et
al
previou
studi
also
show
host
proteas
cathepsin
l
prime
sarscov
membran
fusion
cleavag
site
bosch
et
al
glowacka
et
al
matsuyama
et
al
millet
whittak
shulla
et
al
set
investig
function
determin
smediat
entri
target
cell
use
murin
leukemia
viru
mlv
pseudotyp
system
millet
whittak
assess
abil
promot
entri
target
cell
first
compar
transduct
smlv
sarscov
smlv
cell
known
express
support
sarscov
replic
drosten
et
al
ksiazek
et
al
pseudovirus
enter
cell
equal
well
figur
suggest
smlv
could
use
african
green
monkey
entri
receptor
confirm
result
evalu
entri
bhk
cell
observ
transient
transfect
render
suscept
transduct
smlv
figur
result
demonstr
function
receptor
agreement
recent
report
find
hoffmann
et
al
letko
et
al
zhou
et
al
sequenc
analysi
reveal
presenc
four
amino
acid
residu
insert
boundari
subunit
compar
sarscov
sarsrcov
figur
result
introduct
furin
cleavag
site
featur
conserv
among
isol
sequenc
date
close
relat
zhou
et
al
use
western
blot
analysi
observ
virtual
entir
process
site
biosynthesi
cell
presum
furin
golgi
compart
figur
observ
contrast
sarscov
incorpor
pseudovirion
larg
uncleav
figur
studi
influenc
pseudoviru
entri
furin
cleavag
site
design
mutant
lack
four
amino
acid
residu
insert
furin
cleavag
site
mutat
q
tnsprrarysv
wildtyp
q
tilrysv
furmut
furmut
preserv
conserv
arginin
residu
posit
wildtyp
therebi
mimick
cleavag
site
relat
sarsrcov
figur
furmut
therefor
expect
undergo
process
site
upon
encount
target
cell
similar
sarscov
sarsrcov
ie
via
andor
cathepsin
l
bosch
et
al
glowacka
et
al
matsuyama
et
al
millet
whittak
shulla
et
al
expect
furmut
mlv
harbor
uncleav
upon
bud
figur
observ
transduct
effici
cell
higher
furmut
mlv
smlv
figur
wherea
opposit
trend
observ
transduct
bhk
cell
figur
result
suggest
cleavag
biosynthesi
necessari
smediat
entri
condit
experi
figur
specul
detect
polybas
cleavag
site
fusion
glycoprotein
could
put
expand
tropism
andor
enhanc
transmiss
compar
sarscov
sarsrcov
isol
due
nearubiquit
distribut
furinlik
proteas
report
effect
virus
klenk
garten
millet
whittak
steinhauer
bind
affin
sarscov
correl
overal
rate
viral
replic
distinct
speci
well
transmiss
diseas
sever
guan
et
al
li
et
al
li
et
al
wan
et
al
inde
specif
b
mutat
enabl
effici
bind
sarscov
isol
three
phase
epidem
associ
mark
diseas
sever
consortium
kan
et
al
li
et
al
sui
et
al
contrast
sarscov
isol
detect
brief
reemerg
interact
weakli
low
pathogen
transmiss
consortium
kan
et
al
li
et
al
understand
contribut
receptor
interact
infect
character
engag
b
sarscov
b
sidebysid
use
biolay
interferometri
studi
bind
kinet
affin
purifi
ectodomain
b
sarscov
b
immobil
surfac
biosensor
found
bound
b
sarscov
b
respect
equilibrium
dissoci
constant
nm
figur
nm
figur
compar
kinet
rate
constant
although
offrat
slightli
higher
sarscov
b
tabl
affin
determin
sarscov
b
bind
line
prior
studi
tighter
appar
interact
form
sarscov
b
compar
sarscov
subunit
sarscov
trimer
kirchdoerf
et
al
li
et
al
sui
et
al
wall
et
al
wong
et
al
previou
structur
work
identifi
posit
key
bind
sarscov
b
li
et
al
analysi
genom
sequenc
avail
global
initi
share
influenza
data
gisaid
elb
bucklandmerrett
show
posit
strictli
conserv
b
wherea
posit
semi
conserv
substitut
sarscov
sarscov
sarscov
figur
conserv
mani
key
contact
residu
could
explain
similar
bind
affin
b
sarscov
b
mutat
residu
predict
contact
observ
among
sequenc
avail
date
howev
note
sarsrcov
harbor
close
relat
sequenc
sarsrcov
delet
rbd
could
affect
bind
residu
data
collect
result
suggest
least
well
adapt
k
valu
report
repres
global
fit
data
shown
figur
architectur
glycoprotein
trimer
enabl
singleparticl
cryoem
studi
glycoprotein
design
prefus
stabil
ectodomain
trimer
construct
abrog
furin
cleavag
site
wall
et
al
wall
et
al
wall
et
al
two
consecut
prolin
stabil
mutat
kirchdoerf
et
al
pallesen
et
al
ctermin
foldon
trimer
domain
miroshnikov
et
al
threedimension
classif
cryoem
data
reveal
presenc
multipl
conform
state
correspond
distinct
organ
b
domain
within
apex
approxim
half
particl
imag
select
correspond
trimer
harbor
singl
b
domain
open
wherea
remain
half
account
close
trimer
three
b
domain
close
recent
determin
structur
also
detect
trimer
singl
b
domain
open
none
entir
close
wrapp
et
al
determin
reconstruct
close
ectodomain
trimer
resolut
appli
symmetri
asymmetr
reconstruct
trimer
singl
b
domain
open
resolut
figur
tabl
fusion
machineri
best
resolv
part
map
wherea
b
domain
less
well
resolv
presum
conform
heterogen
atom
model
compris
residu
intern
break
correspond
flexibl
region
includ
part
rbm
lack
ctermin
segment
includ
heptad
repeat
visibl
map
case
structur
determin
date
overal
ectodomain
long
trimer
triangular
crosssect
resembl
close
relat
sarscov
structur
figur
gui
et
al
kirchdoerf
et
al
song
et
al
wall
et
al
yuan
et
al
case
bcoronaviru
glycoprotein
includ
sarscov
gui
et
al
kirchdoerf
et
al
pallesen
et
al
park
et
al
song
et
al
wall
et
al
wall
et
al
wall
et
al
yuan
et
al
subunit
vshape
architectur
figur
close
trimer
three
motif
whose
locat
infer
base
crystal
structur
sarscov
b
complex
li
et
al
buri
interfac
protom
result
b
open
expect
necessari
interact
host
cell
surfac
initi
conform
chang
lead
cleavag
site
membran
fusion
viral
entri
gui
et
al
kirchdoerf
et
al
millet
whittak
pallesen
et
al
park
et
al
song
et
al
wall
et
al
yuan
et
al
sarscov
subunit
share
sequenc
ident
structur
conserv
superimpos
rootmeansquar
deviat
rmsd
align
ca
posit
figur
ntermin
part
fusion
peptid
resolv
map
case
previous
determin
sarscov
structur
sequenc
conform
conserv
fusion
peptid
region
observ
across
sarscov
suggest
ab
target
function
import
motif
might
crossreact
neutral
two
virus
well
relat
coronavirus
previous
show
coronaviru
glycoprotein
dens
decor
heterogen
nlink
glycan
protrud
trimer
surfac
wall
et
al
wall
et
al
xiong
et
al
oligosaccharid
particip
fold
rossen
et
al
affect
prime
host
proteas
yang
et
al
might
modul
antibodi
recognit
pallesen
et
al
wall
et
al
compris
nlink
glycosyl
sequon
per
protom
oligosaccharid
resolv
cryoem
map
site
figur
comparison
sarscov
possess
nlink
glycosyl
sequon
per
protom
previous
experiment
confirm
least
glycosyl
nlink
glycosyl
sequon
conserv
sarscov
tabl
specif
glycan
subunit
glycan
subunit
conserv
among
sarscov
furthermor
nlink
glycosyl
sequon
mostli
conserv
across
sarsrcov
glycoprotein
suggest
access
fusion
machineri
ab
compar
among
virus
tabl
data
map
sequenc
conserv
across
multipl
sequenc
sarbecoviru
subgenu
underscor
fusion
machineri
conserv
subunit
highest
diverg
found
within
b
figur
observ
line
fact
virus
use
entri
receptor
ge
et
al
ren
et
al
yang
et
al
subunit
expos
viral
surfac
fusion
machineri
like
subject
stringent
select
pressur
immun
system
base
observ
hypothes
exposur
one
two
virus
could
elicit
crossreact
potenti
neutral
ab
viru
therefor
investig
abil
plasma
four
mice
immun
stabil
sarscov
inhibit
sand
ac
ribbon
diagram
close
structur
render
surfac
glycan
resolv
cryoem
map
render
dark
blue
sphere
see
also
tabl
data
sarscov
smediat
entri
target
cell
sera
test
complet
inhibit
transduct
sarscov
smlv
reduc
smlv
transduct
control
cell
figur
elicit
heterotyp
respons
block
smediat
entri
host
cell
concur
sequenc
structur
conserv
sarscov
along
compar
glycan
shield
suggest
immun
one
viru
sarbecoviru
subgenu
potenti
provid
protect
relat
virus
receptor
recognit
first
step
viral
infect
key
determin
host
cell
tissu
tropism
enhanc
bind
affin
sarscov
propos
correl
increas
viru
transmiss
diseas
sever
human
li
et
al
inde
sarscov
isol
three
phase
epidem
effici
transmit
among
human
pathogen
isol
associ
reemerg
caus
case
line
bind
affin
consortium
kan
et
al
li
et
al
moreov
abil
engag
differ
anim
speci
appear
reflect
host
suscept
sarscov
infect
facilit
jump
viru
anim
human
li
li
et
al
report
use
entri
receptor
recogn
similar
affin
sarscov
isol
suggest
spread
effici
human
agreement
numer
humantohuman
transmiss
event
report
date
besid
bind
host
cell
receptor
prime
glycoprotein
host
proteas
cleavag
site
anoth
crucial
factor
modul
tropism
pathogen
millet
whittak
instanc
entri
merscovrel
bat
coronaviru
human
cell
requir
addit
exogen
trypsin
indic
proteolyt
activ
bat
viru
occur
human
cell
despit
abil
recogn
human
yang
et
al
subsequ
work
suggest
glycan
present
near
boundari
account
lack
proteolyt
prime
remov
enhanc
pseudoviru
entri
human
cell
yang
et
al
presenc
polybas
cleavag
site
process
furinlik
proteas
signatur
sever
highli
pathogen
avian
influenza
virus
pathogen
newcastl
diseas
viru
klenk
garten
steinhauer
strikingli
harbor
furin
cleavag
site
boundari
process
biosynthesi
presenc
furin
cleavag
site
set
apart
sarscov
sarsrcov
possess
monobas
cleavag
site
process
upon
entri
target
cell
bosch
et
al
glowacka
et
al
matsuyama
et
al
millet
whittak
shulla
et
al
specul
almost
ubiquit
express
furinlik
proteas
could
particip
expand
cell
tissu
tropism
rel
sarscov
well
increas
transmiss
andor
alter
pathogen
previous
suggest
coronavirus
use
conform
mask
glycan
shield
limit
recognit
immun
respons
infect
host
wall
et
al
wall
et
al
xiong
et
al
similarli
sarscov
merscov
gui
et
al
kirchdoerf
et
al
pallesen
et
al
song
et
al
wall
et
al
yuan
et
al
found
trimer
exist
multipl
distinct
conform
state
result
b
open
trimer
apex
structur
chang
necessari
receptor
engag
three
virus
lead
initi
fusogen
conform
chang
song
et
al
wall
et
al
wall
et
al
contrast
close
trimer
detect
four
humaninfect
coronavirus
wall
et
al
kirchdoerf
et
al
known
engag
protein
receptor
b
wong
et
al
wu
et
al
trimer
open
also
expect
occur
expos
rbm
otherwis
buri
interfac
protom
close
trimer
wall
et
al
regardless
natur
receptor
locat
receptorbind
domain
remov
trimer
crown
expect
necessari
coronavirus
allow
largescal
conform
chang
lead
fusion
viral
host
membran
wall
et
al
collect
data
underscor
glycoprotein
trimer
found
highli
pathogen
human
coronavirus
appear
exist
partial
open
state
remain
larg
close
human
coronavirus
associ
common
cold
base
aforement
data
correl
bind
affin
sarscov
rate
transmiss
viral
replic
distinct
speci
diseas
sever
guan
et
al
li
et
al
li
et
al
wan
et
al
hypothes
pathogen
coronavirus
exhibit
glycoprotein
trimer
spontan
sampl
close
open
conform
case
sarscov
merscov
strike
structur
similar
sequenc
conserv
among
sarscov
glycoprotein
emphas
close
relationship
two
virus
recogn
enter
target
cell
resembl
strengthen
find
sarscov
elicit
polyclon
ab
respons
potent
neutral
smediat
entri
cell
surmis
ab
target
highli
conserv
subunit
includ
fusion
peptid
region
base
structur
similar
across
sarscov
lack
crossreact
sever
b
direct
ab
tian
et
al
wrapp
et
al
previou
report
show
sera
sarscovinfect
individu
target
region
zhang
et
al
note
sarscov
neutral
ab
isol
date
target
b
domain
sever
recogn
rbm
prevent
receptor
engag
hwang
et
al
rockx
et
al
rockx
et
al
traggiai
et
al
wall
et
al
sarscov
b
domain
share
amino
acid
sequenc
ident
futur
work
necessari
evalu
whether
ab
neutral
newli
emerg
coronaviru
find
also
indic
might
difficult
distinguish
exposur
sarsrcov
serolog
studi
use
ectodomain
trimer
specif
assay
need
design
result
provid
structur
framework
identifi
conserv
access
epitop
across
glycoprotein
support
ital
font
indic
absenc
glycosyl
sequon
delet
indic
period
glycan
observ
cryoem
map
underlin
see
also
data
cell
march
ongo
vaccin
design
effort
final
elicit
divers
polyclon
ab
respons
might
prove
key
light
divers
virus
circul
anim
reservoir
prevent
possibl
emerg
viral
neutral
escap
mutant
detail
method
provid
onlin
version
paper
includ
follow
top
b
sequenc
align
gener
use
sequenc
obtain
gisaid
addit
sequenc
list
data
c
entri
smlv
sarscov
smlv
potent
inhibit
four
sarscov
mous
polyclon
immun
plasma
inform
request
resourc
reagent
direct
fulfil
lead
contact
david
veesler
dveesler
uwedu
uniquest
reagent
gener
studi
avail
lead
contact
complet
materi
transfer
agreement
number
replic
carri
experi
describ
figuret
legend
cell
line
femal
human
embryon
kidney
cell
line
transform
adapt
grow
suspens
life
technolog
cell
grown
express
medium
life
technolog
cultur
c
co
rpm
femal
human
embryon
kidney
cell
line
atcc
femal
kidney
epitheli
cell
african
green
monkey
bhk
kidney
cell
line
babi
hamster
adher
cell
cultur
c
flask
dmem
fb
penicillinstreptomycin
cell
line
test
mycoplasma
contamin
authent
sarscov
b
construct
clone
sarscov
ectodomain
synthes
geneart
thermofish
scientif
modifi
pope
vector
ntermin
muphosphatas
signal
peptid
ctermin
hexahistidin
tag
ghhhhhh
boundari
construct
ntermin
rvvpsg
ctermin
ldisp
b
construct
synthes
genscript
ntermin
muphosphatas
signal
peptid
ctermin
hexahistidin
tag
ghhhhhh
boundari
construct
ntermin
rfpn
ctermin
stnl
construct
produc
cell
grown
suspens
use
freestyl
express
medium
life
technolog
c
humidifi
co
incub
rotat
rpm
cultur
transfect
use
transfect
reagent
millipor
cell
grown
densiti
million
cell
per
ml
cultiv
day
supernat
harvest
cell
resuspend
anoth
day
yield
two
harvest
protein
purifi
clarifi
supernat
use
cobalt
affin
column
takara
concentr
flash
frozen
buffer
contain
mm
tri
ph
mm
nacl
prior
analysi
sdspage
run
check
puriti
express
purif
human
angiotensinconvert
enzym
ectodomain
residu
fuse
fc
region
human
igg
hfc
perform
previous
describ
cleavag
fc
fragment
carri
thrombin
briefli
produc
cell
grown
suspens
use
freestyl
express
medium
life
technolog
c
humidifi
co
incub
rotat
rpm
cultur
transfect
use
transfect
reagent
millipor
cell
grown
densiti
million
cell
per
ml
cultiv
day
supernat
harvest
cell
resuspend
anoth
four
day
yield
two
harvest
clarifi
supernat
concentr
use
vivaflow
tangenti
filtrat
cassett
sartoriu
cutoff
affin
purif
use
protein
column
ge
lifesci
follow
gel
filtrat
chromatographi
use
superdex
gl
column
ge
life
scienc
equilibr
mm
trishcl
ph
mm
nacl
fc
tag
remov
thrombin
cleavag
reaction
mixtur
contain
mg
recombin
ectodomain
mg
thrombin
mmtrishcl
mm
nacl
mm
cacl
reaction
mixtur
incub
c
overnight
reload
protein
column
remov
uncleav
protein
fc
tag
cleav
protein
purifi
gel
filtrat
use
superdex
column
gl
ge
life
scienc
equilibr
buffer
contain
mm
tri
ph
mm
nacl
purifi
protein
quantifi
use
absorpt
nm
concentr
approxim
mgml
pseudoviru
product
mlvbase
sarscov
furmut
pseudotyp
prepar
previous
describ
millet
whittak
cell
cotransfect
use
lipofectamin
life
technolog
encodingplasmid
mlv
gagpol
packag
construct
mlv
transfer
vector
encod
luciferas
report
accord
manufactur
instruct
cell
incub
h
c
transfect
medium
cell
wash
dmem
two
time
dmem
contain
fb
ad
h
supernat
harvest
filter
membran
concentr
membran
min
rpm
frozen
c
western
blot
sarscov
furmut
pseudovirion
thaw
sd
load
buffer
ad
prior
boil
min
c
sampl
run
gradient
trisglycin
gel
biorad
transfer
pvdf
membran
anti
sarscov
monoclon
primari
antibodi
dilut
alexa
fluor
goat
antihuman
mous
secondari
antibodi
dilut
respect
jackson
laboratori
use
westernblot
licor
processor
use
develop
imag
bhk
cell
cultur
fb
penstrep
dmem
bhk
cell
plate
well
plate
densiti
h
bhk
cell
either
transfect
transfect
mg
per
well
use
standard
life
technolog
protocol
incub
anoth
h
concentr
pseudoviru
ad
well
wash
three
time
dmem
h
fb
penstrep
contain
dmem
ad
cell
h
follow
infect
onegloex
promega
ad
cell
equival
cultur
volum
incub
dark
min
prior
read
varioskan
lux
plate
reader
thermofish
entri
inhibit
assay
dilut
plasma
incub
equal
amount
pseudoviru
min
room
temperatur
prior
infect
normal
amount
pseudoviru
ad
cell
measur
done
triplic
rel
luciferas
unit
rlu
plot
assay
perform
octet
red
fortebio
instrument
c
shake
rpm
antipenta
biosensor
hydrat
water
min
prior
min
incub
kinet
buffer
undilut
either
b
sarscov
b
load
mgml
kinet
buffer
prior
baselin
equilibr
kinet
buffer
associ
kinet
buffer
variou
concentr
twofold
dilut
seri
carri
prior
dissoci
data
baselin
subtract
prior
fit
perform
use
bind
model
fortebio
data
analysi
softwar
mean
k
k
valu
determin
global
fit
appli
data
experi
done
two
separ
purif
batch
sarscov
b
b
duplic
averag
report
genbank
ectodomain
produc
cell
grown
suspens
use
freestyl
express
medium
life
technolog
c
humidifi
incub
rotat
rpm
cultur
transfect
use
thermofish
scientif
cell
grown
densiti
million
cell
per
ml
cultiv
three
day
supernat
harvest
cell
resuspend
anoth
three
day
yield
two
harvest
clarifi
supernat
purifi
use
cobalt
affin
column
takara
purifi
protein
filter
concentr
flash
frozen
buffer
contain
mm
tri
ph
mm
nacl
prior
cryoem
analysi
cryoem
sampl
prepar
data
collect
ml
mgml
load
onto
freshli
glow
discharg
lacey
carbon
grid
thin
layer
evapor
continu
carbon
prior
plung
freez
use
vitrobot
markiv
thermofish
scientif
use
blot
forc
blot
time
humid
c
data
acquir
use
leginon
softwar
suloway
et
al
control
fei
titan
krio
transmiss
electron
microscop
oper
kv
equip
gatan
summit
direct
detector
gatan
quantum
gif
energi
filter
oper
zeroloss
mode
slit
width
ev
autom
data
collect
carri
use
leginon
nomin
magnif
pixel
size
dose
rate
adjust
countspixel
movi
acquir
superresolut
mode
fraction
frame
ms
micrograph
collect
singl
session
defocu
rang
compris
mm
cryoem
data
process
movi
frame
align
estim
microscop
contrasttransf
function
paramet
particl
pick
extract
carri
use
warp
tegunov
cramer
particl
imag
extract
box
size
bin
yield
pixel
size
dataset
two
round
referencefre
classif
perform
use
cryosparc
punjani
et
al
select
welldefin
particl
imag
subsequ
two
round
classif
iter
angular
sampl
iter
local
search
iter
carri
use
relion
zivanov
et
al
without
impos
symmetri
separ
distinct
conform
refin
carri
use
nonuniform
refin
along
perparticl
defocu
refin
cryosparc
punjani
et
al
use
ab
initio
model
gener
use
cryosparc
particl
imag
subject
bayesian
polish
zivanov
et
al
perform
anoth
round
nonuniform
refin
cryosparc
punjani
et
al
follow
perparticl
defocu
refin
nonuniform
refin
local
resolut
estim
filter
sharpen
carri
use
cryosparc
report
resolut
base
goldstandard
fourier
shell
correl
fsc
criterion
fourier
shell
correl
curv
correct
effect
soft
mask
highresolut
nois
substitut
schere
chen
cryoem
model
build
analysi
ucsf
chimera
goddard
et
al
coot
use
fit
atom
model
pdb
cryoem
map
model
subsequ
manual
rebuilt
use
coot
map
brown
et
al
emsley
et
al
model
use
build
featur
specif
nlink
glycan
handbuilt
densiti
visibl
model
refin
relax
use
rosetta
wang
et
al
glycan
refin
reli
dedic
rosetta
protocol
use
physic
realist
geometri
base
prior
knowledg
saccharid
chemic
properti
frenz
et
al
aid
use
sharpen
unsharpen
map
model
analyz
use
molprob
chen
et
al
emring
barad
et
al
phenix
liebschner
et
al
privat
agirr
et
al
valid
stereochemistri
protein
glycan
compon
tabl
figur
gener
use
ucsf
chimerax
goddard
et
al
consurf
ashkenazi
et
al
immun
sarscov
mice
obtain
jackson
laboratori
maintain
compar
medicin
facil
fred
hutchinson
cancer
research
center
collect
preble
mice
immun
sarscov
ectodomain
trimer
construct
previous
describ
formul
pb
sigma
adjuv
system
subcutan
base
tail
week
bleed
collect
week
immun
plasma
immun
anim
heat
inactiv
c
h
store
c
use
experi
conduct
fred
hutchinson
cancer
research
center
accord
approv
institut
anim
care
use
committe
protocol
westernblot
biolay
interferometri
assay
perform
multipl
time
least
two
independ
prepar
sampl
method
use
determin
whether
data
met
assumpt
statist
approach
cryoem
map
atom
model
deposit
electron
microscopi
data
bank
protein
data
bank
access
code
emd
pdb
close
well
emd
pdb
one
b
open
list
softwar
use
studi
found
key
resourc
tabl
